115 related articles for article (PubMed ID: 12675200)
1. Novel effects of On-Chung-Eum, the traditional plant medicine, on cytokine production in human mononuclear cells from Behçet's.
Kim MS; Kim SO; Lim WK; Lee JM; Hwang CY; Cho KH; Kim HM
Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):65-72. PubMed ID: 12675200
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytokine production by the traditional oriental medicine, 'Gamcho-Sasim-Tang' in mitogen-stimulated peripheral blood mononuclear cells from Adamantiades-Behçet's patients.
Kim MS; Chung HS; Lee JG; Lim WK; Hwang CY; Lee EJ; Cho KH; Wi DH; Kim HM
J Ethnopharmacol; 2002 Nov; 83(1-2):123-8. PubMed ID: 12413717
[TBL] [Abstract][Full Text] [Related]
3. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
5. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
6. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
7. In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
Ghozali N; Belguendouz H; Messaoudene D; Hadjimi Z; Ihammichene S; Chekaoui A; Benchabane S; Terahi M; Kediha I; Ali Pacha L; Touil-Boukoffa C
Int Immunopharmacol; 2021 Dec; 101(Pt A):108189. PubMed ID: 34601327
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
11. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X
Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
13. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
14. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
15. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
17. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease].
Song Q; Lu JZ; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells.
Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I
Immunopharmacology; 1998 Jul; 40(1):11-20. PubMed ID: 9776474
[TBL] [Abstract][Full Text] [Related]
19. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]